Integrated Wealth Management (Palm Desert)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-74
Closed -$2K – 760
2016
Q3
$2K Hold
74
– – ﹤0.01% 1076
2016
Q2
$2K Hold
74
– – ﹤0.01% 1088
2016
Q1
$2K Sell
74
-104
-58% -$2.79K ﹤0.01% 1018
2015
Q4
$5K Buy
178
+104
+141% +$2.88K ﹤0.01% 939
2015
Q3
$2K Sell
74
-1,914
-96% -$54.2K ﹤0.01% 1118
2015
Q2
$54K Sell
1,988
-218
-10% -$6.13K 0.02% 385
2015
Q1
$58K Buy
+2,206
New +$50.8K 0.02% 364

Other funds holding NVO

Integrated Wealth Management (Palm Desert)'s NVO Position: Q4 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 74 shares — an estimated $2K sold.

Integrated Wealth Management (Palm Desert) first reported a position in NVO in Q1 2015 and held it in 7 quarters. The position peaked at $58K in Q1 2015. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • Integrated Wealth Management (Palm Desert) reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • Integrated Wealth Management (Palm Desert) sold 74 Novo Nordisk shares in Q4 2016, an estimated $2K.
  • Integrated Wealth Management (Palm Desert) first reported a position in Novo Nordisk in Q1 2015 and held it in 7 quarters.
  • Integrated Wealth Management (Palm Desert)'s Novo Nordisk position peaked at $58K in Q1 2015.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q4 2016, filed 6 Jan 2017.